Human medicines European public assessment report (EPAR): Clopidogrel ratiopharm GmbH, clopidogrel, Peripheral Vascular Diseases,Acute Coronary Syndrome,Myocardial Infarction,Stroke, Date of authorisation: 28/07/2009, Revision: 12, Status: Authorised